(NQ: )

N/A UNCHANGED

Last Price Updated: Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	-
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2018 Financial Results

May 08, 2018

- Achieved positive Phase 2 results for etrasimod in ulcerative colitis in March; Phase 3 preparations for ulcerative colitis and a development plan for Crohn's disease underway

Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares

March 26, 2018

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the completion of its previously announced underwritten public offering of 9,775,000 shares of its common stock at a price to the public of...

Performance

More News

Arena Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference on March 27

March 23, 2018

Rising crude oil prices lift markets to higher close

March 20, 2018

Interesting ARNA Put And Call Options For August 17th

June 28, 2018

First Week of September 21st Options Trading For Arena Pharmaceuticals (ARNA)

June 27, 2018

ARNA June 8th Options Begin Trading

April 26, 2018

Analysts Expect 54% Gains Ahead For The Holdings of XBI

April 03, 2018

ARNA May 11th Options Begin Trading

March 29, 2018

Investors Pick Up ARNA Even Cheaper Than Its Secondary Stock Offering

March 23, 2018

This Obesity Drugmaker Just Made a Comeback While Another Declared Bankruptcy

March 26, 2018

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.